Biotech & Pharma Archive - ARCHIMEDlife

5 years ARCHIMEDlife – Thanks to our partners, clients and friends!

21. November 2017

Today is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve a successful company with...

Read more

Become part of our readers´ community

12. November 2017

You can easily subscribe to our monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...

Read more

Join us: Asia-Pacific Conference on Human Genetics

6. November 2017

You can join us on the 12th Asia-Pacific Conference on Human Genetics “Genomic Medicine and Clinical Practice” from 8th...

Read more

Pharmaboardroom.com: Interview with ARCHIMEDlife CEO David Kasper in Austria issue of “Healthcare and Life Sciences Review”

16. Oktober 2017

Pharmaboardroom.com interviewed ARCHIMEDlife CEO David Kasper for their latest Austria issue of „Healthcare and Life Sciences Review”. Find out...

Read more

ARCHIMEDlife @ MSACL Salzburg: Mass Spectrometry Applications to Clinical Lab, 10.- 4.9.17

13. September 2017

We are proud to be a regular part of MSACL –  this year in Salzburg from 10.- 14. September...

Read more

Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease

5. Juli 2017

Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA)...

Read more

Metabolic progression to clinical phenotype in classic Fabry disease

3. Januar 2017

Background: Fabry disease is an X-linked lysosomal storage disorder due to α-galactosidase A (α-Gal A) deficiency. Clinical onset of...

Read more

The Austrian Toxoplasmosis Register

15. Januar 2015

BACKGROUND: We aimed to determine the incidence of primary gestational infections with Toxoplasma gondii and congenital toxoplasmosis in Austria, a...

Read more

Austrian Newborn Screening Program: A perspective of five decades

13. November 2014

In 1966, the National Austrian Newborn Screening Program for inherited metabolic and endocrine disorders was initiated. In the last...

Read more